<DOC>
	<DOC>NCT02646462</DOC>
	<brief_summary>Prospective investigation of the ratio between malignant and total number of lymph nodes in predefined lymph node stations in patients resected for pancreatic adenocarcinoma. A national Danish project.</brief_summary>
	<brief_title>Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer</brief_title>
	<detailed_description>Lymph nodes will be sampled from the following stations in patients with adenocarcinomas of the pancreas Group 6: Infrapyloric lymph nodes (IP) Group 8: Lymph nodes around the common hepatic artery (CHA) Group 12: Lymph nodes of the hepatoduodenal ligament (HDL) Group 13: Posterior pancreaticoduodenal lymph nodes Group 14: Lymph nodes around the superior mesenteric artery (SMA) Group 17: Anterior pancreaticoduodenal lymph nodes</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Bioptic verified pancreatic adenocarcinoma or periampullary adenocarcinoma (within 20mm of the papilla) Patients with nonadenocarcinoma tumors of the pancreas or periampullary region</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>pancreas adenocarcinoma, lymph node metastases</keyword>
</DOC>